UPDATE: Qiagen Q3 Revenues Climb 5 Percent | GenomeWeb

The story has been updated with comments from a conference call held earlier today.

NEW YORK (GenomeWeb News) – Qiagen reported on Sunday a 5 percent increase in third-quarter revenues year over year, paced by the company's consumables sales.

Revenues in the quarter totaled $304.3 million, up from $288.9 million a year ago and beating the consensus Wall Street estimate of $303.8 million. At constant exchange rates (CER), revenues rose 10 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.